Psychiatry and Neurology, Neurology · Staten Island, NY
NPI
1295700177
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
27 New Dorp Ln
Staten Island, NY, 10306
Phone (718) 667-3597
Groups this clinician bills Medicare through
Medicare paid, 2024
$700K
27,803 services
Medicare patients, 2024
1,362
Average age 73
Drug cost, 2024
$5.8M
7,350 prescriptions
Company payments, 2025
$189K
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allan B Perel was code J0585 (injection, onabotulinumtoxina, 1 unit), 18,058 times for 30 patients. In total Allan B Perel billed 27,803 services in 59 codes, and Medicare paid $700K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 18,058 | 30 | $4.95 | $89K |
| 99214 Office E&M - Established | Office | 1,193 | 740 | $110.18 | $131K |
| 95886 Electrical Nerve Conductivity | Office | 672 | 294 | $86.97 | $58K |
| 99204 Office E&M - New | Office | 403 | 403 | $148.57 | $60K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 235 | 232 | $161.93 | $38K |
| 95910 Electrical Nerve Conductivity | Office | 214 | 213 | $157.04 | $34K |
| 96132 Behavioral Health Services | Office | 183 | 180 | $111.30 | $20K |
| 96138 Behavioral Health Services | Office | 182 | 179 | $32.00 | $5,825 |
| 99232 Hospital E&M - Subsequent | Facility | 166 | 111 | $69.34 | $12K |
| 99483 Office/Outpatient Services | Office | 126 | 123 | $243.45 | $31K |
| 99222 Hospital E&M - Initial | Facility | 111 | 109 | $114.58 | $13K |
| 99213 Office E&M - Established | Office | 108 | 79 | $76.21 | $8,230 |
| 92540 Vision, Hearing, and Speech Services | Office | 92 | 92 | $93.12 | $8,567 |
| 92537 Test - Miscellaneous | Office | 92 | 92 | $34.69 | $3,191 |
| 92546 Vision, Hearing, and Speech Services | Office | 91 | 91 | $121.23 | $11K |
By year: 2022 $916K for 32,371 services; 2023 $795K for 29,057 services; 2024 $700K for 27,803 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allan B Perel prescribed most often to Medicare patients was Gabapentin, with 856 prescriptions and refills. In total Allan B Perel wrote 7,350 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 856 | 1,324 | 231 | $10K |
| Donepezil Hcl Generic | 580 | 1,150 | 167 | $7,816 |
| Memantine Hcl Er Memantine Hcl | 490 | 896 | 119 | $37K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 385 | 851 | 93 | $8,472 |
| Pregabalin Generic | 273 | 277 | 42 | $4,827 |
| Escitalopram Oxalate Generic | 254 | 491 | 76 | $1,819 |
| Levetiracetam Generic | 177 | 317 | 41 | $3,380 |
| Baclofen Generic | 170 | 271 | 31 | $3,791 |
| Rexulti Brexpiprazole | 164 | 178 | 44 | $256K |
| Memantine Hcl Generic | 153 | 340 | 52 | $3,586 |
| Cyclobenzaprine Hcl Generic | 143 | 162 | 54 | $785 |
| Trazodone Hcl Generic | 134 | 159 | 40 | $678 |
| Duloxetine Hcl Generic | 129 | 211 | 39 | $8,059 |
| Dalfampridine Er Dalfampridine | 127 | 149 | 14 | $80K |
| Nurtec Odt Rimegepant Sulfate | 122 | 122 | 25 | $223K |
Brand drugs: 1,271 claims; generic drugs: 6,051 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allan B Perel $189K ($189K in general payments such as food, travel and fees) from 37 companies. The largest payer was TG Therapeutics, Inc. with $40K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 34 | $40K |
| EMD Serono, Inc. MRK.DE | 32 | $26K |
| Axsome Therapeutics, Inc. AXSM | 35 | $20K |
| Abbvie Inc. ABBV | 82 | $18K |
| Vanda Pharmaceuticals Inc. VNDA | 19 | $15K |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $15K |
| Lundbeck LLC | 30 | $13K |
| ANI Pharmaceuticals, Inc. ANIP | 33 | $12K |
| Amgen Inc. AMGN | 16 | $11K |
| Pfizer Inc. PFE | 20 | $8,630 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.